Not for diagnostic or therapeutic use
Because we bypass the traditional brand-name supply chain and the insurance system, we can offer these powerful treatments at a fraction of the retail cost
However, many emerging treatments, such as peptides, remain investigational and not FDA-approved
JHU083 also inhibits the expression of indoleamine 2,3-dioxygenase (IDO) in tumor cells, leading to decreased kynurenine levels and delayed tumor growth and metastasis by enhancing antitumor immune response (Oh et al., 2020)
Over the past several years, she has worked with leading peptide research laboratories and functional medicine clinics, creating trusted, clinically-informed content that bridges the latest developments in peptide and longevity research with real-world applications.